NIAID Sees Notable Increase in Data Access, Storage through Clinical Genomics Program
The agency is improving the way clinical data is linked to patients and making genome sequencing data more available to researchers.
The National Institute of Allergy and Infectious Diseases (NIAID), the national agency dedicated to better understanding and treating disorders of the immune system, requires fast and easy access to data for things like clinical trials and genomic sequencing that are critical to developing new vaccines and treatments. Its Clinical Genomics Program is one way opened up a world of data to researchers. NIAID CIO Mike Tartakovsky highlighted several of the new technologies he has implemented to better share and protect clinical data and touted the agency’s new Biovisualization Lab that is applying virtual reality technology in biomedical research.
-
Mike Tartakovsky CIO NIAID
-
HHS Looks to Centralize IT Buying, Speed Access to Emerging Tech
HHS is centralizing IT procurement while pursuing faster acquisition tools for AI and other emerging technologies.
9m watch -
VA Employees Save 6 Hours a Week With AI Tools
VA AI chief Kimberly McManus said AI tools are helping improve veteran care, reduce opioid overdose mortality and save time for employees.
4m watch -
FEHRM CTO: TEFCA Could Take Federal Health Data Exchange to ‘Next Evolution’
FEHRM CTO Lance Scott discusses efforts to modernize and improve interoperability of electronic health records across the federal government.
7m watch -
Inside ASPR’s Efforts to Bolster Healthcare Sector Cyber Resilience
HHS ASPR’s Bob Bastani details how governance, standards and migration planning can help against emerging threats to medical data and devices.
12m watch